Walk into every congress ready.
Intelliscope scores every abstract against your portfolio and competitors, turns priorities into a coordinated coverage plan, and keeps every decision, note, and interaction linked and searchable, congress after congress.
Your congresses, competitors, KOLs, and portfolio in one place.
A short window, thousands of data points, no shared system.
The moment abstracts are released, your team has days to decide what matters across thousands of new data points. Today that work lives in spreadsheets, slide decks, email threads, and individual memory. It is slow, it is inconsistent, and most of it is gone by the next congress.
Sources
Abstracts
1,362 ingested
Competitors
9 tracked
Portfolio
assets + MoA
Priorities
exec + TA focus
Outputs
Ranked abstracts
with rationale
Coverage plan
owned by session
Briefings
field-ready
Institutional memory
across cycles
Know what matters before you arrive.
Turn thousands of abstracts into a focused plan. Find the science that matters to your company, the people behind it, and the sessions your team needs to cover.
Know what matters before you arrive.
Turn thousands of abstracts into a focused plan. Find the science that matters to your company, the people behind it, and the sessions your team needs to cover.
Find your signal.
KRAS G12C: response durability
Phase II · Oral presentation
Resistance after targeted therapy
Oncology · Research abstract
ctDNA-guided treatment selection
Oncology · Research abstract
Connected to your portfolio.
Relevant to NS-17 and your focus on KRAS G12C resistance.
NS-17 · KRAS G12C- Abstracts to consider
- 6,000
- First pass per abstract
- 3 min
- Manual screening time
- 300 h
Illustrative workload: 6,000 abstracts × 3 minutes = 300 hours. This models manual screening effort, not measured time savings.
Your team, connected. Your congress, in your pocket.
Your day, on your phone
Calendar
Scientific team huddle
Meeting room 2
KRAS G12C readout
Hall A · LB-214
Resistance mechanisms
Poster hall · P-082
See assigned sessions and meetings, times, locations, and conflicts in your personal mobile calendar.
Hall A · Abstract LB-214
Assigned to youTurn every congress into a stronger starting point.
Oncology
Frontiers 2027
Scientific findings, competitive context, and field insights.
Response durability is a priority for follow-up.
The KRAS G12C readout raises questions about prior-treatment subgroups relevant to NS-17.
A competing approach in the same patient population.
Revisit the subgroup data with Dr. Ana Silva.
Generate congress reports
Bring scientific findings, competitive developments, and team observations together in an evidence-linked congress readout.
Response durability is a priority for follow-up.
Abstract LB-214
KRAS G12C: response durability
Dr. Ana SilvaMaya’s observation
Review the prior-treatment subgroup.
12 June · 09:12Keep the evidence close
Trace a conclusion back to its abstract, session, researcher, and field notes. Revisit the discussion behind the finding.
Every congress
adds to the picture.
The first questions
Portfolio priorities and KOL context.
New evidence, more context
This congress’s findings, report, and field notes.
A stronger starting point
Earlier findings inform what to look for and who to meet.
Build compounding memory
Carry portfolio insights, competitor context, and KOL relationships from one congress into preparation for the next.
Before your next congress.
A few answers about the science, the workflow, and getting your team started.
IntelliScope is a congress intelligence and execution platform built for Medical Affairs, Competitive Intelligence, and scientific congress teams. It connects abstract prioritization, team coverage planning, field capture, KOL context, competitor intelligence, and post-congress retrieval in one searchable system.